In summary, our observations indicated that curcumin treatment in line with our hypothesis impeded the progression of MDS to AML and was associated with a lower tumour burden in GFI1-36N, -KD, Nup98-HOXD13-tg mice. This evidence concerns the gene HOXD13 and acute myeloid leukemia.